Caffeic Acid Phenethyl Ester Inhibits Epithelial-Mesenchymal Transition of Human Pancreatic Cancer Cells
Figure 6
Orthotopic pancreatic cancer PANC-1 xenograft. (a) At day 53 and 90, the volumes of the pancreatic tumor were suppressed in the CAPE-treated group although not as effective as gemcitabine. (b) There was a less bone marrow suppression in the CAPE-treated group than the gemcitabine-treated group during the treatment course by serial estimation of WBC counts.
